MSB 4.66% $1.13 mesoblast limited

autologous v allogeneic, page-30

  1. 30,319 Posts.
    lightbulb Created with Sketch. 1836
    Staggering that you have failed to acknowledge that I have nailed you on your irrelevancies with our own reliance on your FDA experience.

    Throw around insults all you like. The FDA has agreed to a review at the half way mark of stage 3 clinical trials with a view to fast track approvals.

    Nothing you say, no personal insults, nothing alters this.

    This is a discussion forum and if I say my best case scenario is early 2017, then that is as valid as your so called FDA experiences.

    Some might say even more so! Look at how quickly things moved in Japan. Very.

    Take a rest. You're trying to blitz the forum and lobbing personal insults shows your arguments are weak.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.055(4.66%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.18 $1.18 $1.13 $4.824M 4.236M

Buyers (Bids)

No. Vol. Price($)
2 25589 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 10000 1
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.